Shares in Bentley-based medical cannabis company Botanix Pharmaceuticals have nearly halved, after it released the results of its clinical trial for acne treatment.
Related Data & Insights
-
Botanix PharmaceuticalsClosing price for the last 90 trading daysPowered by Morningstar ®
-
Rank Company Revenue 132nd Botanix Pharmaceuticals $3.8m 142nd Hazer Group $2.4m 143rd Mustera Property Group $2.3m 145th RemSense Technologies $2.2m 146th BauMart Holdings $2.2m 202 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
27 Nov 2023
Botanix taps investors for $13.5m
25 Aug 2023
Board Moves August 25, 2023
21 Jul 2023
Botanix secures $12.5m placement
17 Apr 2023
Board Moves April 17, 2023
05 Apr 2023
Botanix to raise $10m
07 Nov 2022
Healthtech banks on rising numbers
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX